Join ADAMember Log In




Overview

To help clarify and provide context on oral health issues and dental products, the ADA provides scientific evidence, information and commentary to a wide variety of audiences including the dental profession, media, government agencies and the public. The links below provide access to Association's communications on a number dental product issues.

Click on this link to learn about recent oral health safety alerts.

Return to Top

Letters & Testimony

  • October 15, 2012—Coalition letter advising the Food and Drug Administration (FDA) on the public health impact of rescheduling hydrocodone-containing combination drug products (HCCs) from Schedule III (C-III) to Schedule II (C-II).
  • July 3, 2012—Coalition letter to the Food and Drug Administration on the clinical development and use of sedation products in adult and pediatric age groups.
  • June 15, 2012—Coalition letter urging the House conference committee to retain, amend or strip several drug shortage provisions in H.R. 5651, the Food and Drug Administration Reform Act of 2012.
  • June 15, 2012—Coalition letter urging the Senate conference committee to retain, amend or strip several drug shortage provisions in S. 3187, the Food and Drug Administration Safety and Innovation Act.
  • May 1, 2012—Coalition letter urging the House Committee on Energy and Commerce to make several changes to the drug shortage provisions contained in the discussion draft of H.R. 5651, the Food and Drug Administration Safety and Innovation Act.
  • April 25, 2012—Coalition letter expressing support for the drug shortage provisions in the discussion draft of S. 3187, the Food and Drug Administration Safety and Innovation Act.
  • July 28, 2011—Coalition letter expressing support for S. 296 and its House companion, H.R. 2245, the Preserving Access to Life-Saving Medications Act.
  • April 25, 2011—Letter urging the Food and Drug Administration to address the oral complications associated with reduced salivary flow on the warning labels of medications commonly associated with dry mouth.
  • July 2010—Statement on dental products and BPA exposure.
  • November 20, 2009—News Release on the ADA's petition to the FDA to establish and appropriate regulatory classification for tooth whitening chemicals.
  • March 24, 2009—News Release announcing the results of the ADA's independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.
  • March 16, 2009—Letter informing CDC about the data obtained from the ADA's independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.
  • March 16, 2009—Letter informing FDA about the data obtained from the ADA's independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.
  • December 8, 2008—Letter responding to the FDA's call for comments on the identification of FDA-regulated products that contain bisphenol A (BPA).
  • May 23, 2008—Letter commenting on the National Toxicology Program's Draft Brief on BPA.
  • April 29, 2008—News Release on safety concerns raised by media reports about lead in dental prosthetics such as crowns and bridges.
  • March 18, 2008—Letter urging CDC to assure the public that government agencies are taking appropriate steps to protect dental patients from any possible health impacts of lead in dental prosthetics and that oral health care should not be postponed.
  • March 18, 2008—Letter urging FDA to assure the public that government agencies are taking appropriate steps to protect dental patients from possible health impacts of lead in dental prosthetics and that oral health care should not be postponed.
  • March 6, 2008—Letter informing CDC that the ADA will be carrying out an independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.
  • March 6, 2008—Letter informing FDA that the ADA will be carrying out an independent study of prosthetics from both overseas and domestic labs for trace amounts of lead.
Return to Top

ADA Resources

Return to Top

Additional Resources

Return to Top

Contact Us

For additional information, please contact:

Federal Affairs
1111 14th Street NW, Suite 1100
Washington, DC 20005
202.898.2400
Fax: 202.898.2437
E-mail: govtpol@ada.org

State Government Affairs
ADA Chicago Headquarters
211 East Chicago Avenue
Chicago, IL 60611
312.440.2525
Fax: 312.440.3539
E-mail: govtpol@ada.org

Return to Top